modipafant has been researched along with interleukin-8 in 2 studies
| Studies (modipafant) | Trials (modipafant) | Recent Studies (post-2010) (modipafant) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 29 | 3 | 3 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolanowski, MA; Nourshargh, S; Sanz, MJ; Weg, VB | 1 |
| Au, BT; Collins, PD; Teixeira, MM; Williams, TJ | 1 |
2 other study(ies) available for modipafant and interleukin-8
| Article | Year |
|---|---|
IL-1 is a potent inducer of eosinophil accumulation in rat skin. Inhibition of response by a platelet-activating factor antagonist and an anti-human IL-8 antibody.
Topics: Animals; Antibodies, Monoclonal; Calcium; Chemotaxis, Leukocyte; Dactinomycin; Dihydropyridines; Edema; Eosinophils; Imidazoles; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Interleukin-8; Leukotriene B4; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Sialoglycoproteins; Skin | 1995 |
Blockade of PAF receptors controls interleukin-8 production by regulating the activation of neutrophil CD11/CD18.
Topics: CD11 Antigens; CD18 Antigens; Cells, Cultured; Cytochalasins; Dihydropyridines; Epitopes; Humans; Imidazoles; Interleukin-8; Neutrophil Activation; Neutrophils; Phagocytosis; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Time Factors; Zymosan | 2001 |